Asthma is the most common chronic lung disease of childhood and currently affects nearly 10% of all children in Georgia. It accounts for more than half a million missed school days annually in our state. Unfortunately, asthma is poorly controlled in many of these children and is associated with a high degree of morbidity. Consequently, asthma is the most prevalent disorder managed by physicians at Children’s Healthcare of Atlanta and is also the number one reason for admission to one of the Children’s Healthcare of Atlanta hospitals.
For more information on asthma, click here.
Recruitment of investigators to the asthma research program is underway, including both PhD scientists and physician-scientists. For more information, please contact Dr. Fitzpatrick.
Our team is focused on three areas that will directly impact patients’ lives:
AsthmaNet is a nationwide clinical research network created by the National Heart Lung and Blood Institute in 2009. The purpose of AsthmaNet is to develop and conduct multiple clinical trials that explore new approaches in treating asthma from childhood through adulthood. AsthmaNet studies are being conducted in 13 states.
The Severe Asthma Research Program (SARP) is the world’s most comprehensive study of adults and children with severe asthma, linking 7 asthma clinical university centers through a National Heart, Lung and Blood Institute Sponsored Network. To date, over 1500 asthma patients have participated. The network’s mission is to improve the understanding of severe asthma in order to develop better treatments.
Emory/Children’s is one of 7 clinical centers participating in a study of asthma prevention in newborns. This study will determine whether an oral therapy administered to high-risk newborns prevents episodes of wheezing associated with lower respiratory tract illnesses.